LWCFA
COGT icon

Loring Wolcott & Coolidge Fiduciary Advisors’s Cogent Biosciences COGT Stock Holding History

Loring Wolcott & Coolidge Fiduciary Advisors’s Portfolio COGT Stock Details COGT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$77.4K Hold
2,000
– – ﹤0.01% 402
2026
Q1 		$72.7K Buy
2,000
+1,000
+100% +$36.9K ﹤0.01% 403
2025
Q4 		$38.5K Hold
1,000
– – ﹤0.01% 435
2025
Q3 		$14.8K Hold
1,000
– – ﹤0.01% 492
2025
Q2 		$7.18K Hold
1,000
– – ﹤0.01% 489
2025
Q1 		$4.47K Hold
1,000
– – ﹤0.01% 509
2024
Q4 		$8.47K Hold
1,000
– – ﹤0.01% 493
2024
Q3 		$12K Buy
+1,000
New +$9.74K ﹤0.01% 490

Other funds holding COGT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return
EA
Emerald Advisers Leola, Pennsylvania $4.25B AUM 141.71% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
SCM
Silverarc Capital Management Boston, Massachusetts $962M AUM 524.64% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Loring Wolcott & Coolidge Fiduciary Advisors's COGT Position: Q2 2026 in Review

Loring Wolcott & Coolidge Fiduciary Advisors held its Cogent Biosciences (COGT) position steady in Q2 2026 at 2,000 shares worth $77.4K. The position accounts for ﹤0.01% of the portfolio, ranked #402.

Loring Wolcott & Coolidge Fiduciary Advisors first reported a position in COGT in Q3 2024 and has held it in 8 quarters since. 163 funds tracked by Wall St. Rank hold COGT as of Q2 2026.

  • Loring Wolcott & Coolidge Fiduciary Advisors held 2,000 shares of Cogent Biosciences worth $77.4K as of Q2 2026.
  • Loring Wolcott & Coolidge Fiduciary Advisors left its Cogent Biosciences share count unchanged in Q2 2026.
  • Cogent Biosciences made up ﹤0.01% of Loring Wolcott & Coolidge Fiduciary Advisors's portfolio in Q2 2026, its #402 holding.
  • Loring Wolcott & Coolidge Fiduciary Advisors first reported a position in Cogent Biosciences in Q3 2024 and has held it in 8 quarters since.
  • 163 funds tracked by Wall St. Rank held Cogent Biosciences as of Q2 2026.

Based on Loring Wolcott & Coolidge Fiduciary Advisors's 13F filing for Q2 2026, filed 30 Jul 2026.